Moreover, the combination of TSLP with neutrophil infiltration is associated with worse patient prognosis and survival, suggesting that GBM may contribute to immunomodulation of the tumor microenvironment through the production of TSLP, as previously reported [93,94,95]. The gene discussed is TSLP; the disease is glioblastoma.